Show results for
Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Automobile & Ground Transport
- Defense
- Electronics and Computers
- Aerospace & Air Transport
- Chemical & Pharmaceuticals
- Waste and Recycling
- Oil, Gas & Refineries
- Environmental
- Health and Safety
- Air and Climate
- University / Academia / Research
- Government
- Manufacturing, Other
- Food and Beverage
Epilepsy Suppliers In France
6 companies found
based inParis, FRANCE
Qynapse, through QyScore, brings groundbreaking peace of mind to the global fight against CNS disease. Qyscore is a medical device software FDA-cleared – class II and CE-marked – class IIa (CE BSI). Qyscore is a medical device software FDA-cleared ...
QyScore is a groundbreaking neuroimaging analysis platform for both clinical routine and clinical trial settings. One scan at a time, QyScore has the potential to revolutionize the treatment of CNS disease and create the potential for earlier ...
based inInnsbruck, AUSTRIA
IONICON is the world's leading manufacturer of ultra-sensitive real-time trace gas analyzers based on the unique Proton Transfer Reaction – Mass Spectrometry (PTR-MS) and proprietary SRI-MS technology. IONICON also produces industrial process ...
based inMarchaux - Chaudefontaine, FRANCE
DIXI medical, Manufacturer of intracerebral electrodes for the localization of epileptic foci for over 40 years. For more than 40 years, DIXI medical never ceased to innovate and improve its intracerebral electrodes and implantation accessories, ...
based inMiddleton, WISCONSIN (USA)
We are Gilson, a third generation family-owned company developing liquid handling, purification, and extraction solutions with a focus on helping the life scientist at the bench achieve more productive research and verifiable data. Since 1957, we ...
based inBoston, MASSACHUSETTS (USA)
SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 790 institutions in over 70 countries. Our network advances data-driven medicine to improve health outcomes and economics worldwide. We offer a ...
Most rare and inherited diseases have a neurological component, likely because more than 80% of human genes are expressed in the brain.1 Neurological disorders are multifactorial and heterogeneous, meaning that their genetic basis is often poorly ...
based inParis, FRANCE
Metabolism is the most fundamental force driving and sustaining life At Metafora, we leverage our knowledge and understanding of cellular metabolism to develop innovative and impactful solutions that change patients’ lives. At METAFORA, we are ...
METAglut1 is an in Vitro Diagnostic Medical Device used to aid in the diagnosis of the GLUT1 Deficiency Syndrome (GLUT1DS). It is a regulated health product that bears the CE mark. The first test for the daily practice developed from the METAdiag ...